Ashley Nicole Sutherland Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-1347 Fax: 636-461-1718 |
Dr. Daniel Joseph Fischer, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-6030 |
Mr. Edward Joseph Baum, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2766 Kings Crossing Dr, Barnhart, MO 63012 Phone: 636-942-2625 |
Lindsay Hall Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-1347 |
Mark Fox Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-1347 Fax: 636-461-1718 |
Dr. Katherine Michele Brust, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-1347 Fax: 636-461-1718 |
Mary Susan Ail, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-1347 |
Dr. Jeff Snellen Ii, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Catlin Dr, Barnhart, MO 63012 Phone: 636-461-1347 |
News Archive
Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision support tool that uses a combination of patient information and characteristics to assist physicians and patients with decisions about blood thinning treatment to prevent strokes in individuals with atrial fibrillation.
Good news for the millions of people who suffer from skin wounds that won't heal. A team of researchers at The Ohio State University has brought a potentially transformative solution to the problem by creating a portable adhesive patch that drives a continuous, small electrical current to stimulate healing and reduce the risk of infection.
Gentiva Health Services, Inc., one of the largest providers of home health, hospice and community care services in the United States, today reported fourth quarter and full-year 2013 results.
Agent-based models (ABMs) are powerful computer-simulation modeling techniques that used increasingly to understand a broad range of biological phenomena, such as tumor growth, the immune system, and the spread of infectious diseases through a population.
Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to LantusĀ® (insulin glargine).
› Verified 6 days ago